Constant Companion Partners with Canary Speech to Help Diagnose Behavioral Health Trends
Constant Companion and Canary Speech have formed a new strategic partnership to study how voice technology can be used to identify some conditions in older adults.
Constant Companion will be making its voice-operated, AI-powered platform available to older adults and their caregivers to facilitate better communication and monitoring. Canary Speech will analyze the data with its patented speech digital biomarker technology, used to diagnose behavioral conditions and other diseases. Ultimately the study, which will be conducted under informed consent using de-identified data, will enhance the information available to clinical teams about their patients and increase quality of care.
The partnership will help both companies put metrics around human conditions and define which patterns reveal certain diseases. Canary Speech will analyze both the words and the emotions of study subjects to capture critical mental and behavioral health data that can help identify depression, anxiety, or stress. The company has identified more than 2,500 biomarkers in speech that are consistent for some diseases across a range of individuals.
"Today marks an important milestone for AI-powered voice technology in the future of healthcare innovation," said Mark Gray, founder and CEO of Constant Companion, in a statement. "Healthcare requires human-centered, value-based solutions built on trust, confidence, and connection. The partnership between Canary Speech and Constant Companion helps deliver that at scale."
"This is truly a groundbreaking partnership that will allow us to analyze data that will help advance the care of our aging population," said Henry O'Connell, founder and CEO of Canary Speech, in a statement. "Our ultimate goal is to study these biomarkers and increase the quality of care clinical teams provide to patients."
Constant Companion's voice system keeps older adults engaged, connected, and protected with just their voices.
It's now possible to detect everything from depression to Parkinson's disease with speech analytics, but privacy concerns are still being dealt with
Canary Speech announced that the U.S. Patent and Trademark Office has granted to Canary Speech a patent for broader claims for its inventions.